Furthermore, phospho-proteomics data obtained from human post-mortem brain samples revealed a decrease in MECP2 S423 phosphorylation in the early stages of AD with respect to AD-related neurofibrillary pathology. Here, MECP2 is linked to Alzheimer disease.